Zai Lab Ltd SEC filings ZLAB
Zai Lab Ltd has 739 filings in SEC EDGAR's recent list, going back to May 30, 2017. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Dec 22, 2023 | Dec 31, 2022 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 20-F/A | Amended annual report (foreign issuer) | Sep 18, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2020 | Dec 31, 2019 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 23, 2019 | Dec 31, 2018 |
| 20-F/A | Amended annual report (foreign issuer) | Jun 26, 2019 | Jun 25, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2019 | Dec 31, 2018 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2018 | Dec 31, 2017 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZLAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Shanghai
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1704292
- Former names
- Zai Lab Ltd (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.